Overview
Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)
Status:
Completed
Completed
Trial end date:
2008-12-01
2008-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study evaluates the safety and tolerability of Asenapine in elderly patients with psychosis.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Asenapine
Criteria
Inclusion Criteria:- Elderly subjects with psychosis
Exclusion Criteria:
- Have an uncontrolled, unstable clinically significant
medical condition.
- Have an established diagnosis of dementia